Schedule 13G ownership disclosure

BriaCell Therapeutics Corp.

13G · CUSIP: 10778Y104

Event date: 2025-08-25

Filing-level shares
13,338.61
Percent of class
100.0%
  • Plambeck Jeremy Myung Jae

    Shares: 13,338.61 · Class: 100.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002090655-25-000002
Form type
SCHEDULE 13G
Filer
BriaCell Therapeutics Corp.
CIK
CIK 1610820
Filed
Oct 10, 2025
Reporting period
Aug 25, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub